emlyon is gaining a foothold in France's leading site for the production of active ingredients and Europe's leading region for the production of human and veterinary vaccines.

In a further move to develop its healthcare activities, emlyon has become an associate member of the Lyonbiopôle competitiveness cluster, a catalyst in the healthcare innovation ecosystem in Auvergne-Rhône-Alpes, which comprises top-level institutional, industrial, hospital and academic professionals.

Becoming an associate member of Lyonbiopôle builds on the momentum initiated by emlyon with its "Résonances" 2024-2028 strategic plan and boosted by the recent launch of the HITS (Healthcare Innovation, Technology & Society) Institute, which coordinates healthcare training programs, research activities and entrepreneurship in this sector.

The association with Lyonbiopôle coincides with emlyon business school's move to its new campus in the center of Lyon, in the district of Gerland, close to drug, diagnostic and vaccine companies, life sciences research entities, biotechnology companies and international organizations. Welcoming emlyon as an associate member of Lyonbiopôle enables this catalyst for the health innovation ecosystem in Auvergne-Rhône-Alpes to count on an additional institution of higher education – one that is among the most recognized in its field, and whose expertise will benefit the activities federated by the competitiveness cluster.

For Isabelle Huault, Executive President and Dean, emlyon business school

« Becoming an associate member of Lyonbiopôle is a decisive step in the pathway of developing health activities under the “Résonances” 2024-2028 strategic plan. For the whole of the emlyon business school community, this step forward boosts the opportunities for interaction with industrial, academic, hospital and institutional professionals, serving one of the largest healthcare ecosystems in Europe. »

For Florence Agostino-Etchetto, Executive Director of Lyonbiopôle AuvergneRhône-Alpes:

“We are delighted that emlyon business school is joining our health innovation community as an associate member. This partnership will enable future innovators trained by the School to interact with our ecosystem, in order to better understand their needs and provide an effective response. The arrival in Gerland of a higher education establishment of this caliber, coupled with the creation of the HITS Institute, both testify to the appeal of our region in the field of life sciences.”

Download the press release

About emlyon business school:

Founded in 1872 by the Lyon Chamber of Commerce, emlyon business school has an enrollment of over 9,260 students of 130 nationalities across four campuses worldwide (Lyon, Shanghai, Paris, and Mumbai). The School relies on a Faculty of 170 internationally recognized professors and researchers, and a network of 222 global academic partners, to provide learning tracks of academic excellence open to the world. The school runs a community of 45,000 alumni spread over 130 countries. As a benefit corporation (société à mission) emlyon aims to “train and support informed leaders, throughout their lives, who are able to transform organizations efficiently for a fairer society and with greater solidarity and respect for the planet”. The School's pedagogy closely links action and reflection. Skill hybridization and social responsibility are also at the heart of its training programs, where the best of both socioeconomic and academic worlds meet. The strategic plan, “Resonances 2028”, reaffirms the importance of the “maker spirit” that has been the DNA of emlyon since its creation. The plan is built around the five qualities expected of “makers”, emlyon students and alumni, to become entrepreneurs of change, namely: academic excellence; entrepreneurial spirit; engagement; hybrid knowledge; resonance with society.

More information on: www.em-lyon.com

About Lyonbiopôle:

Designated a competitiveness cluster when it was created in 2005, Lyonbiopole AuvergneRhône-Alpes is the catalyst for the health innovation ecosystem in Auvergne-Rhône-Alpes, facilitating connections, fostering growth, and advancing the field. As an expert in the healthcare market, the cluster supports biotech, medtech/in vitro diagnostics and digital health-tech projects and companies, and sets out to strengthen the development of technological innovations, products and services to meet tomorrow's healthcare challenges. It facilitates collaboration and project coordination with the region's hospitals and clinics. Lyonbiopôle Auvergne-Rhône-Alpes currently unites, advises and supports 256 members - companies, academics and hospitals - in their projects for innovation, growth, internationalization and hosting. Its members include 6 founders (4 major manufacturers, namely Sanofi, bioMérieux, Boehringer Ingelheim Santé Animale and Becton Dickinson, along with the CEA and Fondation Mérieux), 15 major groups, subsidiaries and mid-market companies, 208 innovative SMEs, 15 research and training centers, 6 healthcare and research establishments, 1 local authority and 5 associate members.

More information on: www.lyonbiopole.com